Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19.
bioRxiv [Preprint]. 2021 Feb 12:2020.09.12.293498. doi: 10.1101/2020.09.12.293498.
bioRxiv. 2021.
PMID: 32935104
Free PMC article.
Updated.
Preprint.
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19.
Boras B, Jones RM, Anson BJ, Arenson D, Aschenbrenner L, Bakowski MA, Beutler N, Binder J, Chen E, Eng H, Hammond H, Hammond J, Haupt RE, Hoffman R, Kadar EP, Kania R, Kimoto E, Kirkpatrick MG, Lanyon L, Lendy EK, Lillis JR, Logue J, Luthra SA, Ma C, Mason SW, McGrath ME, Noell S, Obach RS, O' Brien MN, O'Connor R, Ogilvie K, Owen D, Pettersson M, Reese MR, Rogers TF, Rosales R, Rossulek MI, Sathish JG, Shirai N, Steppan C, Ticehurst M, Updyke LW, Weston S, Zhu Y, White KM, García-Sastre A, Wang J, Chatterjee AK, Mesecar AD, Frieman MB, Anderson AS, Allerton C.
Boras B, et al. Among authors: lillis jr.
Nat Commun. 2021 Oct 18;12(1):6055. doi: 10.1038/s41467-021-26239-2.
Nat Commun. 2021.
PMID: 34663813
Free PMC article.
Item in Clipboard
Self-Assembly Properties of an Amphiphilic Phosphate Ester Prodrug Designed for the Treatment of COVID-19.
O'Brien Laramy MN, Bezawada P, Horst R, Jaini R, Lillis J, Liu Y, Luthra S, Nguyen B, Patel N, Soni S, Sullivan BP, Thiel A, Ticehurst MD.
O'Brien Laramy MN, et al.
J Pharm Sci. 2023 Aug 4:S0022-3549(23)00317-9. doi: 10.1016/j.xphs.2023.07.024. Online ahead of print.
J Pharm Sci. 2023.
PMID: 37543257
Item in Clipboard
Cite
Cite